Thailand courts PH for biopharma partnership
By Andrea B. Ramos
BANGKOK, Thailand — Thailand has extended an official invitation to the Philippines to collaborate in developing the region’s biopharmaceutical industry, offering access to its state-of-the-art National Biopharmaceutical Facility (NBF) as part of a broader push to strengthen ASEAN cooperation in life sciences, technology transfer, and investment.
The invitation was made by officials of the National Biopharmaceutical Facility (NBF) at King Mongkut’s University of Technology Thonburi (KMUTT) during a media tour on July 7 ahead of CPHI South East Asia 2026, where international journalists were given an inside look at the country’s integrated biopharmaceutical research and manufacturing ecosystem.
The facility, one of Thailand’s flagship investments in life sciences, is positioning itself as a regional hub for research, pilot manufacturing, workforce development, and pharmaceutical innovation.
Speaking to THEPHILBIZNEWS, Asst. Prof. Suchada Chaisawadi, adviser to the NBF, formally invited the Philippines to join Thailand’s growing network of regional collaborators.
“We already have Malaysian funding, but we need the Philippines. We need Vietnam to make a collaboration,” Chaisawadi said.
She noted that Philippine researchers, universities, government agencies, and biotechnology companies can leverage the facility from product design and laboratory research through pilot-scale production and commercialization.
The collaboration could accelerate the Philippines’ efforts to build its own biopharmaceutical capabilities while reducing the need for significant upfront investments in specialized research infrastructure.
Dr. Warinthorn Songkasiri, KMUTT Vice President for Research Strategy and Acting Director of the NBF, said the facility is designed not only for Thailand but also for neighboring countries seeking to establish or strengthen their biopharmaceutical industries.
“If your country wants to develop the biopharmaceutical industry, we provide services for qualification and verification, capacity building, facilities and infrastructure,” Songkasiri said.
Beyond laboratory services, the NBF offers technical training, specialized workshops, consultancy, plant design, and assistance in developing facilities that comply with Good Manufacturing Practice (GMP) standards.
The facility also supports technology validation and industrial-scale production, helping bridge the gap between scientific research and commercial manufacturing.
Investment opportunity for the Philippines
The invitation comes as the Philippines continues to strengthen its healthcare, biotechnology, and pharmaceutical sectors while seeking greater foreign investment in high-value industries.
Industry observers say collaboration with Thailand’s NBF could provide Philippine universities, government research institutions, hospitals, and pharmaceutical companies with access to advanced infrastructure, specialized expertise, and regional research partnerships without immediately investing in similar large-scale facilities.
For Thailand, the initiative forms part of its long-term strategy to establish itself as ASEAN’s leading life sciences and biopharmaceutical innovation hub.
The NBF was established to enhance vaccine security, accelerate biotechnology research, and support pharmaceutical manufacturing while encouraging cross-border collaboration among ASEAN economies.
By opening its facilities to neighboring countries, Thailand is positioning itself as a regional partner in advancing healthcare innovation, talent development, and investment in the rapidly growing biopharmaceutical sector.
No comments: